arrow
Y

Yuki Imaoka

hiroshima university
H指数:13
被引数:817
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Advancing precision medicine in hepatocellular carcinoma: current challenges and future directions in liquid biopsy, immune microenvironment, single nucleotide polymorphisms, and conversion therapy

Akabane, M.; Imaoka, Y.; Kawashima, J.; Pawlik, T.M. 推进肝细胞癌的精准医学:液体活检、免疫微环境、单核苷酸多态性和转化治疗领域的当前挑战与未来方向。Hepatic Oncol. 2025, 12, 2493457. [Google Scholar] [CrossRef] [PubMed]

2025-12-318
PRE
Beyond the Composite: Differential Impact of Albumin and Bilirubin Relative to Tumor Burden in HCC

超越综合指标:白蛋白和胆红素相对于肝癌肿瘤负荷的差异化影响

2025-11-260
PRE
The Surgical Burden Score: A Novel Continuous Metric for Predicting Postoperative Complications After Hepatectomy for Hepatocellular Carcinoma

手术负担评分:一种预测肝细胞癌肝切除术后并发症的新型连续指标

HPB
IF2.4
2025-08-210
PRE
International validation of a natural-killer-cell–based model to predict recurrence-free survival in hepatocellular carcinoma

基于自然杀伤细胞模型的肝癌无复发生存预测模型的国际验证

HPB
IF2.4
2025-07-030
PRE
Impact of disparity between imaging and pathological tumor size on cancer-specific prognosis among patients with hepatocellular carcinoma
EJSO
IF2.9
2025-06-010
PRE
Dynamic ALBI score and FIB-4 index trends to predict complications after resection of hepatocellular carcinoma: A K-means clustering approach
EJSO
IF2.9
2025-06-010
PRE
Unraveling the obesity paradox in hepatocellular carcinoma: relative role of elevated body mass index on detrimental effects of postoperative complications

解析肝细胞癌中的肥胖悖论:升高体重指数对术后并发症有害影响的相对作用

HPB
IF2.4
2025-05-280
PRE
Enhancing outcome prediction in patients with colorectal liver metastases undergoing hepatectomy: the synergistic impact of FIB-4 index and tumor burden score across KRAS profiles

在行肝切除术的结直肠癌肝转移患者中增强预后预测:FIB-4指数与肿瘤负荷评分在KRAS谱系中的协同影响

HPB
IF2.4
2025-04-140
PRE
Enhancing Recurrence-Free Survival Prediction in Hepatocellular Carcinoma: A Time-Updated Model Incorporating Tumor Burden and AFP Dynamics
2025-04-011
OAAI